Suprabhat Giri

974 total citations
107 papers, 415 citations indexed

About

Suprabhat Giri is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Suprabhat Giri has authored 107 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 43 papers in Hepatology and 40 papers in Epidemiology. Recurrent topics in Suprabhat Giri's work include Liver Disease and Transplantation (34 papers), Liver Disease Diagnosis and Treatment (34 papers) and Gallbladder and Bile Duct Disorders (22 papers). Suprabhat Giri is often cited by papers focused on Liver Disease and Transplantation (34 papers), Liver Disease Diagnosis and Treatment (34 papers) and Gallbladder and Bile Duct Disorders (22 papers). Suprabhat Giri collaborates with scholars based in India, United States and Singapore. Suprabhat Giri's co-authors include Akash Shukla, Shivaraj Afzalpurkar, Vaneet Jearth, Sridhar Sundaram, Babu P. Mohan, Akash Roy, Hemant Deshmukh, Xingshun Qi, CE Eapen and Masayoshi Kage and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Suprabhat Giri

83 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suprabhat Giri India 11 224 167 148 137 110 107 415
A. Fung Hong Kong 12 337 1.5× 205 1.2× 104 0.7× 113 0.8× 183 1.7× 41 506
Hideo Uehara Japan 14 291 1.3× 354 2.1× 290 2.0× 75 0.5× 95 0.9× 42 545
Shigeho Maenohara Japan 13 167 0.7× 52 0.3× 75 0.5× 173 1.3× 126 1.1× 30 383
Pedro Amaro Portugal 13 222 1.0× 84 0.5× 83 0.6× 141 1.0× 147 1.3× 66 428
Young Mi Hong South Korea 11 97 0.4× 155 0.9× 148 1.0× 86 0.6× 114 1.0× 44 341
Cinzia Nobili Italy 10 192 0.9× 117 0.7× 84 0.6× 102 0.7× 165 1.5× 18 333
Kai-hong Huang China 7 150 0.7× 42 0.3× 93 0.6× 82 0.6× 87 0.8× 10 328
Yung‐Hsiang Yeh Taiwan 10 288 1.3× 78 0.5× 165 1.1× 248 1.8× 114 1.0× 22 517
Neshan Tabibian United States 11 254 1.1× 96 0.6× 76 0.5× 116 0.8× 66 0.6× 22 423
Sakhawat H. Rahman United Kingdom 12 434 1.9× 56 0.3× 116 0.8× 108 0.8× 245 2.2× 20 594

Countries citing papers authored by Suprabhat Giri

Since Specialization
Citations

This map shows the geographic impact of Suprabhat Giri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suprabhat Giri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suprabhat Giri more than expected).

Fields of papers citing papers by Suprabhat Giri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suprabhat Giri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suprabhat Giri. The network helps show where Suprabhat Giri may publish in the future.

Co-authorship network of co-authors of Suprabhat Giri

This figure shows the co-authorship network connecting the top 25 collaborators of Suprabhat Giri. A scholar is included among the top collaborators of Suprabhat Giri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suprabhat Giri. Suprabhat Giri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulkarni, Anand V., Karan Kumar, Suprabhat Giri, et al.. (2025). Infections in Standard or Tapered Dose of Prednisolone for Alcohol-Associated Hepatitis: A Randomized Trial (STASH Trial). The American Journal of Gastroenterology. 120(12). 2821–2831. 1 indexed citations
2.
Chavan, Radhika, et al.. (2025). Understanding the Basics of Linear Endoscopic Ultrasound: A Step-by-Step Guide to Anatomy and Orientation. Journal of Digestive Endoscopy. 16(2). 77–90.
3.
Giri, Suprabhat, et al.. (2025). Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia‐Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021. Journal of Gastroenterology and Hepatology. 40(5). 1188–1201. 3 indexed citations
4.
Nath, Preetam, et al.. (2024). Etiological Profile of Obstructive Jaundice and Acute Cholangitis: Three-year Data from a Tertiary Care Center in Eastern India. Euroasian Journal of Hepato-Gastroenterology. 14(2). 187–190. 2 indexed citations
5.
Giri, Suprabhat, et al.. (2024). PREDICTORS OF FAILURE OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN CLEARING BILE DUCT STONES DURING INDEX PROCEDURE - A PROSPECTIVE STUDY. Arquivos de Gastroenterologia. 61. e23112–e23112. 5 indexed citations
6.
Shah, Bhavik, et al.. (2023). Diagnostic efficacy of endoscopic ultrasound-guided liver biopsy for diffuse liver diseases and its predictors – a multicentric retrospective analysis. Clinical and Experimental Hepatology. 9(3). 243–250. 7 indexed citations
7.
Giri, Suprabhat, et al.. (2023). Comparison of efficacy and safety of endoscopic and radiological interventions for gastric varices: A systematic review and network meta-analysis. Clinical and Experimental Hepatology. 9(1). 57–70. 7 indexed citations
9.
Giri, Suprabhat, et al.. (2023). Impact of macroscopic on‐site evaluation on the diagnostic outcomes of endoscopic ultrasound‐guided fine‐needle aspiration. Diagnostic Cytopathology. 51(9). 569–574. 5 indexed citations
10.
Giri, Suprabhat, et al.. (2023). Eosinophilic Esophagitis in the Setting of Prior Caustic Ingestion. Cureus. 15(2). e35536–e35536. 1 indexed citations
11.
Giri, Suprabhat, et al.. (2023). Atezolizumab plus bevacizumab versus lenvatinibas first-line therapy for advanced hepatocellularcarcinoma: A systematic review and meta-analysis. Clinical and Experimental Hepatology. 9(3). 228–235. 1 indexed citations
12.
Giri, Suprabhat, et al.. (2023). Natural history of portal vein thrombosis in cirrhosis: A systematic review with meta‐analysis. Journal of Gastroenterology and Hepatology. 38(10). 1710–1717. 8 indexed citations
13.
Giri, Suprabhat, et al.. (2023). Noninvasive differentiation of porto-sinusoidal vascular disorder from cirrhosis: a systematic review. Abdominal Radiology. 48(7). 2340–2348. 3 indexed citations
14.
Giri, Suprabhat, et al.. (2023). Comparison of suction techniques for EUS-guided tissue acquisition: Systematic review and network meta-analysis of randomized controlled trials. SHILAP Revista de lepidopterología. 11(8). E703–E711. 8 indexed citations
15.
Giri, Suprabhat, et al.. (2023). Role of contrast‐enhanced ultrasound for differentiation of benign vs. malignant portal vein thrombosis in hepatocellular carcinoma – A systematic review a meta‐analysis. Australasian Journal of Ultrasound in Medicine. 27(1). 56–64. 2 indexed citations
16.
Roy, Akash, et al.. (2023). Saroglitazar in Non-alcoholic Fatty Liver Disease From Bench to Bedside: A Comprehensive Review and Sub-group Meta-Analysis. Cureus. 15(10). e47493–e47493. 6 indexed citations
17.
Giri, Suprabhat, et al.. (2022). Review: Disposable Duodenoscopes in the Era of Climate Change—A Global Perspective. 12(1). 11–17. 2 indexed citations
18.
Sundaram, Sridhar, et al.. (2022). Outcomes and predictors of response to endotherapy in pancreatic ductal disruptions with refractory internal and high-output external fistulae. Annals of Hepato-Biliary-Pancreatic Surgery. 26(4). 347–354. 3 indexed citations
20.
Sundaram, Sridhar, et al.. (2021). Outcomes of Dilation of Recalcitrant Pancreatic Strictures Using a Wire-Guided Cystotome. Clinical Endoscopy. 54(6). 903–908. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026